/Companies

FluoretiQ Ltd

Bristol, GB · 2 known investors

Find your way into FluoretiQ Ltd

Sign up to see every warm intro you have to FluoretiQ Ltd

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the FluoretiQ Ltd team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

FluoretiQ develops rapid point-of-care diagnostic tools that identify bacteria and determine effective antibiotics for veterinarians and clinicians, aiming to reduce reliance on empirical antibiotic treatment. Its NANOPLEX latex agglutination platform underpins its first product, VERI-5 VET, and its SCFI platform provides growth-free antibiotic susceptibility testing.

Founders & leadership

NDNeciah Dorh
Neciah DorhCo-founder & CEOCo-founder & CEO at FluoretiQ
JE
Josephine Esposito-ElstonFounder & Co-inventor of NANOPLEX

Investors · 2

Companies House · registry record

View on Companies House ↗
Registered name
FLUORETIQ LIMITED
Company number
10647632
Status
Active
Company type
Private limited company
Incorporated
2 Mar 2017
Registered office
Future Space, Filton Road, Bristol, BS34 8RB
Nature of business (SIC)
72190 — Other research and experimental development on natural sciences and engineering
Accounts
last made up to 31 Mar 2025 · next due 31 Dec 2026
Confirmation statement
last made up to 1 Mar 2026 · next due 15 Mar 2027

Current officers · 4

  • Josephine Ndoa Dorh — director, appointed 2 Mar 2017
  • Neciah Dorh — director, appointed 2 Mar 2017
  • William Pelling — director, appointed 2 Sept 2024
  • Deepbridge Ned Limited — corporate director, appointed 5 Apr 2024

Source: Companies House public register · retrieved 16 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.

Frequently asked questions

What does FluoretiQ Ltd do?
FluoretiQ develops rapid point-of-care diagnostic tools that identify bacteria and determine effective antibiotics for veterinarians and clinicians, aiming to reduce reliance on empirical antibiotic treatment. Its NANOPLEX latex agglutination platform underpins its first product, VERI-5 VET, and its SCFI platform provides growth-free antibiotic susceptibility testing.
Who founded FluoretiQ Ltd?
FluoretiQ Ltd was founded by Neciah Dorh, Josephine Esposito-Elston.
Who are FluoretiQ Ltd's investors?
FluoretiQ Ltd's investors include Deepbridge Capital, Oxford Investment Opportunity Network (OION).
Where is FluoretiQ Ltd headquartered?
FluoretiQ Ltd is headquartered in Bristol, GB.